Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis

Clinical trial NCT05938361 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05938361
Sponsor: Clin4all
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Psoriasis Palmaris Psoriasis Genital Psoriasis of Scalp Psoriasis Plantaris Psoriasis Nail

Start date: 2023-06-01
Primary completion: 2024-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.